Conference

Online Conference

July 13th – 14th, 2021

Innovation Flow in the Healthcare

Innovation Flow in the Healthcare
Innovation Flow in the Healthcare

The main hurdles and challenges of innovation in healthcare should be addressed from a regional perspective using high-level coordination through international and/or national policies.

A strong network of different national and regional authorities as well as academia, industry, and society, as setting up the Quadruple Helix model will be necessary to overcome all barriers. As innovation is intrinsically connected with personalised medicine, the promotion of innovation into healthcare will directly lead to an improvement of the patient-centered approach.

Many countries and regions have been implementing different innovation tools in their own healthcare systems such as Innovative Procurement and monitoring programmes for the purpose of fostering the routine use of these technologies within hospitals.

Moreover, following the aim of boosting the innovation flow based on personalised medicine, other actions in their infrastructures have been carried out by various healthcare organisations such as adapting their facilities for testing new products and prototypes. Collaboration among hospitals and industry in research and innovation activities enables large improvements in healthcare systems.

Relevant outcomes have been achieved, promoting the application of personalised medicine technologies in Europe. These contributions will trigger new policies and investments at regional, national, interregional, and European levels.

#InnovationFlow #PersonalisedHealthcare #PersonalisedMedicine #EuropeanRegions

Programme

Day 1, July 13th

Check-in to online system and introduction to the system

10.00

Host greetings from Galicia

Antonio Fernández-Campa – Managing Director, Galician Health Knowledge Agency (ACIS), Galicia (Spain)

10.05

Introduction Regions4PerMed: the project, aim of the conference

Gianni D’Errico – Toscana Life Sciences Foundation, Firenze (Italy)

10.10

Galician health knowledge ecosystem

José María Romero Fidalgo – Director Health Development and Innovation Area (ACIS), Galicia (Spain)

10.20

Galician Health Service Strategy in Personalised Medicine

Jorge Aboal Viñas – General Director of the Health Assistance Department, Galician Health Service (SERGAS), Galicia (Spain)

SESSION I

Research and Innovation (R&I) models to boost innovation

10.30

ELIXIR in the European Research Infrastructure landscape

Dr. Gary Saunders – ELIXIR Human Data Coordinator, Cambridge (UK)

10.50

Clinical and scientific prevention programmes: thinking about tomorrow

Prof. Andrea Damiani – Gemelli Generator, Rome (Italy)

11.10

Harmonising Health Living Lab Infrastructures Procedures and Services

Evdokimos Konstantinidis – Council Member of the European Network of Living Labs (ENoLL), Thessaloniki  (Greece)

11.30

Q&A

Short Break

SESSION II

Financial instruments to support innovation

11.40

Financial programmes as a driving force to Research & Innovation developments in Personalised Medicine

Dr. Cristina Bescos – Senior Director in Digital Health, European Institute of Innovation and Technology (EIT) Health Spain, Catalonia (Spain)

12.00

Supporting EU health care systems through Innovation Procurement (Pre-Commercial Procurement, PCP, and Public Procurement of Innovation, PPI)

Orestis Kalliantzidis – Policy/Project Officer, EU Commission, Luxembourg (Luxembourg)

12.20

Q&A

Discussion

Poll

12.40

Closing Remarks

Gianni D’Errico – Toscana Life Sciences Foundation, Firenze (Italy)

12.45

End of Day 1

Day 2, July 14th

10.00

Check-in to online system and introduction to the system

10.05

Introduction Regions4PerMed: the Project, Aim of the Conference

Gianni D’Errico – Toscana Life Sciences Foundation, Firenze (Italy)

Session III

Innovative Procurement Tools: Pre-Commercial Procurement (PCP) and Public Procurement of Innovation (PPI)

10.10

Why PPI? Benefits of PPI

Ramón Maspons Bosch – Chief Innovation Officer, Agency for Health Quality and Assessment – AQuAS, Catalonia (Spain)

10.30

Main barriers to overcome in PPI & PCP-based projects

Rossana Alessandrello – Chief Procurement Officer, Agency for Health Quality and Assessment – AQuAS, Catalonia (Spain)

10.50

PCP/PPI approaches & the European Assistance For Innovation Procurement (EAFIP)-methodology

Ana Lucía Jaramillo – Legal Procurement Researcher, Corvers Procurement Services B.V., ‘s-Hertogenbosch (The Netherlands)

11.10

Q&A

Short Break

11.20

Galician experience in ICT PPI-based projects

Javier Quiles del Río – IT Manager at Galician Health Service, Galician Health Service (SERGAS), Galicia (Spain)

11.40

Galician experience in new/advanced therapies PCP/PPI-based projects

Alicia Piñeiro Redondo – Director Consultancy Services, Galaria (SERGAS), Galicia (Spain)

12.00

Discussion and Poll

12.10

Wrap Up

12.15

End of Event